Luis A. Cervera-Chi

Christus Muguerza Hospital Faro Del Mayab SA De CV
Merida, YUC, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Metabolic index a non-invasive predictive marker of liver steatosis in patients with Non-Alcoholic Fatty Liver Disease

Metabolic index a non-invasive predictive marker of liver steatosis in patients with Non-Alcoholic Fatty Liver Disease

Journal: Medicina clinica

Published: April 14, 2025

Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.

Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach.

Journal: World journal of gastroenterology

Published: November 28, 2023

Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?

Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?

Journal: Neurogastroenterology and motility

Published: September 26, 2022

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.

Journal: World journal of hepatology

Published: February 17, 2022

Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.

Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.

Journal: European journal of gastroenterology & hepatology

Published: August 17, 2021

Body composition and phase angle by bioimpedance in patients with MAFLD.

Body composition and phase angle by bioimpedance in patients with MAFLD.

Journal: Gastroenterologia y hepatologia

Published: August 02, 2021

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study.

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study.

Journal: Revista de gastroenterologia de Mexico (English)

Published: July 14, 2021

Increased incidence of and microbiologic changes in pyogenic liver abscesses in the Mexican population.

Increased incidence of and microbiologic changes in pyogenic liver abscesses in the Mexican population.

Journal: World journal of hepatology

Published: May 25, 2020

Sodium-Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes.

Sodium-Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes.

Journal: Hepatology (Baltimore, Md.)

Published: January 24, 2020

Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®).

Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®).

Journal: Journal of medical biochemistry

Published: December 27, 2019

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: November 29, 2017

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis.

Journal: World journal of gastroenterology

Published: August 09, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026